US Stock MarketDetailed Quotes

XLO Xilio Therapeutics

Watchlist

1.060
+0.010+0.95%

Close Jun 10 16:00 ET

39.13MMarket Cap-412P/E (TTM)

Xilio Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

58.41%-10.5M

9.38%-68.62M

26.32%-13.43M

32.85%-13.37M

1.09%-16.57M

-21.19%-25.25M

6.23%-75.72M

-6.18%-18.22M

3.91%-19.91M

16.79%-16.76M

Net income from continuing operations

24.04%-17.2M

13.40%-76.4M

21.41%-17.66M

15.37%-16.75M

21.36%-19.36M

-6.06%-22.65M

-16.39%-88.22M

-14.03%-22.47M

-21.78%-19.79M

-6.18%-24.61M

Operating gains losses

----

200.00%3K

--0

--1K

----

-99.55%1K

--0

----

Depreciation and amortization

-11.22%443K

2.87%1.9M

-8.18%449K

-2.75%460K

10.56%492K

13.41%499K

23.22%1.85M

24.11%489K

23.82%473K

19.30%445K

Other non cash items

-103.23%-1K

-29.60%157K

-72.88%16K

-60.34%23K

64.15%87K

-41.51%31K

28.90%223K

13.46%59K

34.88%58K

32.50%53K

Change In working capital

189.87%4.43M

-182.73%-1.66M

-2.50%1.83M

141.00%1.03M

-91.40%400K

-145.76%-4.93M

116.98%2M

10,344.44%1.88M

58.92%-2.52M

193.93%4.65M

-Change in receivables

---30M

----

--0

----

-Change in prepaid assets

-538.92%-1.78M

100.00%688K

236.85%1.29M

-491.08%-1.67M

27.26%663K

20.83%406K

110.97%344K

-303.69%-939K

119.37%426K

133.59%521K

-Change in payables and accrued expense

46.44%-2.8M

-191.21%-1.89M

-77.27%665K

199.12%2.82M

-103.42%-145K

-132.58%-5.23M

124.54%2.07M

936.00%2.93M

26.10%-2.84M

31.21%4.23M

-Change in other current assets

17.59%127K

17.65%460K

18.45%122K

17.00%117K

17.71%113K

17.39%108K

17.77%391K

17.05%103K

17.65%100K

18.52%96K

-Change in other current liabilities

-14.55%-244K

-14.61%-918K

-13.81%-239K

-14.63%-235K

-14.93%-231K

-15.14%-213K

-42.02%-801K

-16.02%-210K

-15.17%-205K

-14.86%-201K

-Change in other working capital

--39.12M

----

Cash from discontinued investing activities

Operating cash flow

58.41%-10.5M

9.38%-68.62M

26.32%-13.43M

32.85%-13.37M

1.09%-16.57M

-21.19%-25.25M

6.23%-75.72M

-6.18%-18.22M

3.91%-19.91M

16.79%-16.76M

Investing cash flow

Cash flow from continuing investing activities

73.97%-486K

59.01%-316K

33.07%-170K

-69.73%-1.87M

-34.66%-509K

-192.11%-333K

-76.03%-771K

Net PPE purchase and sale

--0

73.97%-486K

--0

59.01%-316K

33.07%-170K

-69.73%-1.87M

-34.66%-509K

-192.11%-333K

-76.03%-771K

Cash from discontinued investing activities

Investing cash flow

--0

73.97%-486K

--0

59.01%-316K

33.07%-170K

-69.73%-1.87M

-34.66%-509K

-192.11%-333K

-76.03%-771K

Financing cash flow

Cash flow from continuing financing activities

156.52%954K

-9,392.75%-6.55M

-7,680.95%-1.63M

-10,063.64%-2.24M

-4,623.81%-992K

-33,660.00%-1.69M

-100.03%-69K

-100.02%-21K

-107.31%-22K

93.98%-21K

Net issuance payments of debt

-98.70%-3.35M

-7,843.53%-6.75M

-7,938.10%-1.69M

-10,100.00%-2.24M

-5,290.48%-1.13M

-7,938.10%-1.69M

22.73%-85K

4.55%-21K

-107.67%-22K

94.07%-21K

Net common stock issuance

--4.31M

----

--0

----

Proceeds from stock option exercised by employees

----

1,162.50%202K

--54K

--8K

----

-94.35%16K

--0

Cash from discontinued financing activities

Financing cash flow

156.52%954K

-9,392.75%-6.55M

-7,680.95%-1.63M

-10,063.64%-2.24M

-4,623.81%-992K

-33,660.00%-1.69M

-100.03%-69K

-100.02%-21K

-107.31%-22K

93.98%-21K

Net cash flow

Beginning cash position

-62.04%46.29M

-38.91%121.95M

-56.40%61.35M

-52.19%76.96M

-46.87%94.84M

-38.91%121.95M

860.15%199.61M

38.87%140.7M

32.10%160.96M

25.03%178.51M

Current changes in cash

64.78%-9.55M

2.58%-75.66M

19.69%-15.06M

22.99%-15.61M

-1.90%-17.88M

-28.51%-27.11M

-143.43%-77.66M

-119.08%-18.75M

1.31%-20.26M

16.13%-17.55M

End cash Position

-61.26%36.74M

-62.04%46.29M

-56.40%61.35M

-52.19%76.96M

-46.87%94.84M

-38.91%121.95M

38.87%140.7M

32.10%160.96M

Free cash flow

58.69%-10.5M

10.93%-69.11M

28.32%-13.43M

33.95%-13.37M

3.63%-16.89M

-20.54%-25.42M

5.21%-77.59M

-6.80%-18.73M

2.84%-20.24M

14.81%-17.53M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	58.41%-10.5M	9.38%-68.62M	26.32%-13.43M	32.85%-13.37M	1.09%-16.57M	-21.19%-25.25M	6.23%-75.72M	-6.18%-18.22M	3.91%-19.91M	16.79%-16.76M
Net income from continuing operations	24.04%-17.2M	13.40%-76.4M	21.41%-17.66M	15.37%-16.75M	21.36%-19.36M	-6.06%-22.65M	-16.39%-88.22M	-14.03%-22.47M	-21.78%-19.79M	-6.18%-24.61M
Operating gains losses	----	200.00%3K	--0	--1K	----	----	-99.55%1K	--0	----	----
Depreciation and amortization	-11.22%443K	2.87%1.9M	-8.18%449K	-2.75%460K	10.56%492K	13.41%499K	23.22%1.85M	24.11%489K	23.82%473K	19.30%445K
Other non cash items	-103.23%-1K	-29.60%157K	-72.88%16K	-60.34%23K	64.15%87K	-41.51%31K	28.90%223K	13.46%59K	34.88%58K	32.50%53K
Change In working capital	189.87%4.43M	-182.73%-1.66M	-2.50%1.83M	141.00%1.03M	-91.40%400K	-145.76%-4.93M	116.98%2M	10,344.44%1.88M	58.92%-2.52M	193.93%4.65M
-Change in receivables	---30M	----	----	----	----	--0	----	----	----	----
-Change in prepaid assets	-538.92%-1.78M	100.00%688K	236.85%1.29M	-491.08%-1.67M	27.26%663K	20.83%406K	110.97%344K	-303.69%-939K	119.37%426K	133.59%521K
-Change in payables and accrued expense	46.44%-2.8M	-191.21%-1.89M	-77.27%665K	199.12%2.82M	-103.42%-145K	-132.58%-5.23M	124.54%2.07M	936.00%2.93M	26.10%-2.84M	31.21%4.23M
-Change in other current assets	17.59%127K	17.65%460K	18.45%122K	17.00%117K	17.71%113K	17.39%108K	17.77%391K	17.05%103K	17.65%100K	18.52%96K
-Change in other current liabilities	-14.55%-244K	-14.61%-918K	-13.81%-239K	-14.63%-235K	-14.93%-231K	-15.14%-213K	-42.02%-801K	-16.02%-210K	-15.17%-205K	-14.86%-201K
-Change in other working capital	--39.12M	----	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	58.41%-10.5M	9.38%-68.62M	26.32%-13.43M	32.85%-13.37M	1.09%-16.57M	-21.19%-25.25M	6.23%-75.72M	-6.18%-18.22M	3.91%-19.91M	16.79%-16.76M
Investing cash flow
Cash flow from continuing investing activities	0	73.97%-486K	0	0	59.01%-316K	33.07%-170K	-69.73%-1.87M	-34.66%-509K	-192.11%-333K	-76.03%-771K
Net PPE purchase and sale	--0	73.97%-486K	--0	--0	59.01%-316K	33.07%-170K	-69.73%-1.87M	-34.66%-509K	-192.11%-333K	-76.03%-771K
Cash from discontinued investing activities
Investing cash flow	--0	73.97%-486K	--0	--0	59.01%-316K	33.07%-170K	-69.73%-1.87M	-34.66%-509K	-192.11%-333K	-76.03%-771K
Financing cash flow
Cash flow from continuing financing activities	156.52%954K	-9,392.75%-6.55M	-7,680.95%-1.63M	-10,063.64%-2.24M	-4,623.81%-992K	-33,660.00%-1.69M	-100.03%-69K	-100.02%-21K	-107.31%-22K	93.98%-21K
Net issuance payments of debt	-98.70%-3.35M	-7,843.53%-6.75M	-7,938.10%-1.69M	-10,100.00%-2.24M	-5,290.48%-1.13M	-7,938.10%-1.69M	22.73%-85K	4.55%-21K	-107.67%-22K	94.07%-21K
Net common stock issuance	--4.31M	----	----	----	----	--0	----	----	----	----
Proceeds from stock option exercised by employees	----	1,162.50%202K	--54K	--8K	----	----	-94.35%16K	--0	--0	--0
Cash from discontinued financing activities
Financing cash flow	156.52%954K	-9,392.75%-6.55M	-7,680.95%-1.63M	-10,063.64%-2.24M	-4,623.81%-992K	-33,660.00%-1.69M	-100.03%-69K	-100.02%-21K	-107.31%-22K	93.98%-21K
Net cash flow
Beginning cash position	-62.04%46.29M	-38.91%121.95M	-56.40%61.35M	-52.19%76.96M	-46.87%94.84M	-38.91%121.95M	860.15%199.61M	38.87%140.7M	32.10%160.96M	25.03%178.51M
Current changes in cash	64.78%-9.55M	2.58%-75.66M	19.69%-15.06M	22.99%-15.61M	-1.90%-17.88M	-28.51%-27.11M	-143.43%-77.66M	-119.08%-18.75M	1.31%-20.26M	16.13%-17.55M
End cash Position	-61.26%36.74M	-62.04%46.29M	-62.04%46.29M	-56.40%61.35M	-52.19%76.96M	-46.87%94.84M	-38.91%121.95M	-38.91%121.95M	38.87%140.7M	32.10%160.96M
Free cash flow	58.69%-10.5M	10.93%-69.11M	28.32%-13.43M	33.95%-13.37M	3.63%-16.89M	-20.54%-25.42M	5.21%-77.59M	-6.80%-18.73M	2.84%-20.24M	14.81%-17.53M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall